Reckitt Benckiser Group (LON:RKT) Price Target Raised to GBX 6,100

Reckitt Benckiser Group (LON:RKT) had its price objective increased by JPMorgan Chase & Co. from GBX 5,500 to GBX 6,100 in a report released on Wednesday, MarketBeat Ratings reports. They currently have a neutral rating on the stock.

Several other equities research analysts also recently issued reports on RKT. Royal Bank Of Canada raised their price target on Reckitt Benckiser Group from GBX 6,000 to GBX 6,400 and gave the company an “outperform” rating in a research report on Thursday, October 23rd. Berenberg Bank cut their price objective on Reckitt Benckiser Group from GBX 5,920 to GBX 5,555 and set a “hold” rating for the company in a research report on Wednesday, August 6th. UBS Group reaffirmed a “buy” rating and issued a GBX 7,700 target price on shares of Reckitt Benckiser Group in a report on Friday, October 17th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 5,200 price target on shares of Reckitt Benckiser Group in a research report on Thursday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the stock a “buy” rating in a report on Friday, October 24th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 6,109.17.

Reckitt Benckiser Group Stock Performance

LON:RKT opened at GBX 5,852 on Wednesday. Reckitt Benckiser Group has a 1 year low of GBX 4,579 and a 1 year high of GBX 6,014. The firm’s fifty day simple moving average is GBX 5,785.71 and its 200 day simple moving average is GBX 5,450.33. The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 110.26. The firm has a market capitalization of £39.47 billion, a PE ratio of 32.15, a PEG ratio of 1.10 and a beta of 0.09.

Insider Buying and Selling

In other Reckitt Benckiser Group news, insider Patricia Verduin purchased 135 shares of the firm’s stock in a transaction on Wednesday, October 29th. The shares were purchased at an average price of GBX 5,867 per share, for a total transaction of £7,920.45. 0.42% of the stock is currently owned by company insiders.

About Reckitt Benckiser Group

At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.

Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.

We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.

At Reckitt, we’re all making a real difference to people all over the world, every day.